Retinoid X receptor α controls innate inflammatory responses through the up-regulation of chemokine expression
The retinoid X receptor α (RXRα) plays a central role in the regulation of many intracellular receptor signaling pathways and can mediate ligand-dependent transcription by forming homodimers or heterodimers with other nuclear receptors. Although several members of the nuclear hormone receptor superf...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 107; no. 23; pp. 10626 - 10631 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
08.06.2010
National Acad Sciences |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The retinoid X receptor α (RXRα) plays a central role in the regulation of many intracellular receptor signaling pathways and can mediate ligand-dependent transcription by forming homodimers or heterodimers with other nuclear receptors. Although several members of the nuclear hormone receptor superfamily have emerged as important regulators of macrophage gene expression, the existence in vivo of an RXR signaling pathway in macrophages has not been established. Here, we provide evidence that RXRα regulates the transcription of the chemokines Cd6 and Cd9 in macrophages independently of heterodimeric partners. Mice lacking RXRα in myeloid cells exhibit reduced levels of CCL6 and CCL9, impaired recruitment of leukocytes to sites of inflammation, and lower susceptibility to sepsis. These studies demonstrate that macrophage RXRα plays key roles in the regulation of innate immunity and represents a potential target for immunotherapy of sepsis. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited* by Daniel Steinberg, University of California, La Jolla, CA, and approved April 19, 2010 (received for review November 25, 2009) 1V.N. and D.A. contributed equally to this work. Author contributions: T.F., L.B., C.K.G., A.G.A., and M.R. designed research; V.N., D.A., D.R., R.M., P.G., and M.C. performed research; T.F. contributed new reagents/analytic tools; V.N., D.A., D.R., R.M., P.G., T.F., L.B., A.G.A., and M.R. analyzed data; and C.K.G., A.G.A., and M.R. wrote the paper. 2Present address: Structural Biology and Biocomputing Programme, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.0913545107 |